HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeutics.

Abstract
Purple acid phosphatases are metalloenzymes found in animals, plants and fungi. They possess a binuclear metal centre to catalyse the hydrolysis of phosphate esters and anhydrides under acidic conditions. In humans, elevated purple acid phosphatases levels in sera are correlated with the progression of osteoporosis and metabolic bone malignancies, making this enzyme a target for the development of new chemotherapeutics to treat bone-related illnesses. To date, little progress has been achieved towards the design of specific and potent inhibitors of this enzyme that have drug-like properties. Here, we have undertaken a fragment-based screening approach using a 500-compound library identifying three inhibitors of purple acid phosphatases with K(i) values in the 30-60 μm range. Ligand efficiency values are 0.39-0.44 kcal/mol per heavy atom. X-ray crystal structures of these compounds in complex with a plant purple acid phosphatases (2.3-2.7 Å resolution) have been determined and show that all bind in the active site within contact of the binuclear centre. For one of these compounds, the phenyl ring is positioned within 3.5 Å of the binuclear centre. Docking simulations indicate that the three compounds fit into the active site of human purple acid phosphatases. These studies open the way to the design of more potent and selective inhibitors of purple acid phosphatases that can be tested as anti-osteoporotic drug leads.
AuthorsDaniel Feder, Waleed M Hussein, Daniel J Clayton, Meng-Wei Kan, Gerhard Schenk, Ross P McGeary, Luke W Guddat
JournalChemical biology & drug design (Chem Biol Drug Des) Vol. 80 Issue 5 Pg. 665-74 (Nov 2012) ISSN: 1747-0285 [Electronic] England
PMID22943065 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 John Wiley & Sons A/S.
Chemical References
  • Enzyme Inhibitors
  • Glycoproteins
  • purple acid phosphatase
  • Acid Phosphatase
Topics
  • Acid Phosphatase (antagonists & inhibitors, chemistry)
  • Amino Acid Sequence
  • Animals
  • Catalytic Domain
  • Crystallography, X-Ray
  • Drug Design
  • Enzyme Inhibitors (chemistry, pharmacology)
  • Glycoproteins (antagonists & inhibitors, chemistry)
  • Humans
  • Molecular Docking Simulation
  • Molecular Sequence Data
  • Osteoporosis (drug therapy, enzymology)
  • Phaseolus (chemistry, enzymology)
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: